「primary」の検索結果

Detects and removes infostealer malware (credential stealers, data exfiltrators) via full-system file search, cryptographic hashing, and public threat-intelligence cross-checks (VirusTotal, MalwareBazaar). Primary method is always custom hash-based detection. Windows Defender (or any platform-native AV) is allowed **only when necessary** (e.g. inconclusive hashes or deep remediation) and **must never be the default option**. The agent must exhaust the custom workflow first. Works on Windows/macOS/Linux.

日本語の概要は準備中です。原文の説明を表示しています。

Create, iterate, and scale paid ad creative for Google Ads, Meta, LinkedIn, TikTok, and similar platforms. Use when generating headlines, descriptions, primary text, or large sets of ad variations for testing and performance optimization.

日本語の概要は準備中です。原文の説明を表示しています。

Investigate a question against high-trust primary sources and capture the findings as a Markdown file in the repo. Use when the user wants a topic researched, docs or API facts gathered, or reading legwork delegated to a background agent.

日本語の概要は準備中です。原文の説明を表示しています。

Manual testing + bug filing for Enterprise / SaaS products. Parses a Feishu test doc (scope + repo + bitable URL), observes staging via claude-in-chrome, captures DOM/console/network/screenshot evidence, then dual-tracks each finding — Feishu Bitable record (with attachments) + GitHub issue (<REPO>#<ISSUE_NUMBER> format — English-primary, Chinese collapsed, R2-hosted screenshots, matching type label). Enforces dedup across bitable + GitHub issues + PRs, and mandatory P0/P1/P2 priority prompt when unclear. Trigger whenever the user says "test and report", "test and report side-by-side", "start system testing", "experience staging", "collaborate on bug filing", "collect feedback", a shared Feishu testing doc, a bitable URL + finding, or any UX/bug needing both bitable + GitHub tracking. Do NOT use for writing product code, PR review, CI debugging, or general "how do I use this product" questions — those go to normal dev / PR-review / support flows.

日本語の概要は準備中です。原文の説明を表示しています。

Create, iterate, and scale paid ad creative for Google Ads, Meta, LinkedIn, TikTok, and similar platforms. Use when generating headlines, descriptions, primary text, or large sets of ad variations for testing and performance optimization.

日本語の概要は準備中です。原文の説明を表示しています。

tespit etme (s) and responds to OAuth token theft and replay attacks in cloud environments, focusing on Microsoft Entra ID (Azure AD) token protection, conditional access policies, and sign-in anomaly Tespit. Covers access token theft, refresh token replay, Primary Refresh Token (PRT) abuse, and pass-the-cookie attacks. Activates for requests involving OAuth token theft Tespit, token replay prevention, Azure AD conditional access token protection, or cloud identity attack investigation.

日本語の概要は準備中です。原文の説明を表示しています。

Change the sync configuration of an existing data warehouse schema — switch sync_type, pick a different incremental_field, set primary_key_columns, choose cdc_table_mode, or change sync_frequency. Use when the user asks "switch my orders table from full refresh to incremental", "this table is syncing too slowly / too frequently", "I need to pick a different incremental column", "set up CDC for this Postgres table", or when diagnosis of a failing sync pointed to an incremental-field or PK misconfiguration.

日本語の概要は準備中です。原文の説明を表示しています。

Implements missing-data sensitivity analyses for confirmatory clinical trials including MMRM under MAR (with Kenward-Roger correction), reference-based multiple imputation (J2R, CR, CIR, LMCF per Carpenter-Roger 2013), Permutt delta-adjustment / tipping-point analysis, pattern-mixture identifying restrictions (CCMV, NCMV, ACMV), and the Cro vs Bartlett variance debate. Use when handling missing primary or secondary endpoint data in regulatory submissions following NRC 2010 and ICH E9(R1).

日本語の概要は準備中です。原文の説明を表示しています。

Synthesize scientific evidence into a claim-to-source matrix, distinguish primary evidence from interpretation, assess disagreement and study limitations, and produce a calibrated research summary.

日本語の概要は準備中です。原文の説明を表示しています。

End-to-end clinical trial analysis workflow from CDISC SDTM/ADaM loading through ICH E9(R1) estimand-driven primary analysis to CONSORT 2025 regulatory-compliant reporting. Covers data preparation, FDA 2023 marginal vs conditional logistic regression, categorical tests with Boschloo, modern HTE/subgroup methods, missing-data sensitivity (MMRM, reference-based MI, Permutt tipping point), graphical multiplicity (Bretz-Maurer), survival analysis (Cox/RMST/competing risks) when applicable, and Table 1. Use when performing a complete analysis of clinical trial data.

日本語の概要は準備中です。原文の説明を表示しています。

Trace drug mechanism of action — primary target → downstream signaling → pathway perturbation → tissue/organ effect → clinical outcome. Uses DrugBank, ChEMBL, KEGG, Reactome, STRING. Use for understanding how a drug works, identifying off-target effects, mechanism-based combination therapy design, and writing mechanism sections of reports.

日本語の概要は準備中です。原文の説明を表示しています。

Comprehensive drug profiling — mechanism, primary/secondary targets, drug interactions, clinical-trial status, adverse events (FAERS), pharmacogenomics, and approval history. Use for full drug investigation reports, 'tell me about drug X' queries, and assembling drug profiles for clinicians, researchers, or regulatory work.

日本語の概要は準備中です。原文の説明を表示しています。

Use when you need to review, improve, or build Spring Boot 4.0.x applications — including proper usage of @SpringBootApplication, component annotations (@Controller, @Service, @Repository), bean definition and scoping, configuration classes and @ConfigurationProperties (with @Validated), component scanning, conditional configuration and profiles, constructor injection, @Primary and @Qualifier for multiple beans of the same type, bean minimization, graceful shutdown, virtual threads, Jakarta EE namespace consistency, and scheduled tasks. This should trigger for requests such as Review Java code for Spring Boot application; Apply best practices for Spring Boot application in Java code. Part of cursor-rules-java project

日本語の概要は準備中です。原文の説明を表示しています。

Book reservations through Google Maps using browser automation. Searches for businesses, checks availability, and completes bookings via "Reserve with Google" or 3rd-party providers (OpenTable, Resy, Vagaro). Supports restaurants (primary), salons, fitness, healthcare. Use when user wants to book, reserve, or schedule at a business found on Google Maps.

日本語の概要は準備中です。原文の説明を表示しています。

Research a specific company before applying or interviewing by gathering facts from primary and official sources, recording the source and date behind every claim, and keeping anonymous or unverifiable material clearly separated from confirmed fact. Use when a user asks what a company actually does, how it makes money, what its published conditions are, whether a posting matches the company's own disclosures, or what to verify before an interview; do not use to predict hiring outcomes, to repeat review-site content as fact, or to bulk-crawl sites that prohibit automated access.

日本語の概要は準備中です。原文の説明を表示しています。

Assembles haplotype-resolved diploid and telomere-to-telomere (T2T) genomes from PacBio HiFi reads with hifiasm (HiFi-only, Hi-C, or trio phasing) and verkko (HiFi + ultralong ONT for T2T), extracting contigs from GFA and routing phasing QC to k-mer/trio metrics. Covers why a primary assembly is a haplotype mosaic that exists in no cell, partial-vs-full phasing (the .bp. vs .dip. filename convention), the purge-default trap on inbred samples, the --hom-cov coverage-estimate alarm, and verkko-vs-hifiasm for T2T. Use when assembling a diploid eukaryote from HiFi, phasing haplotypes with parents (trio) or Hi-C, deciding whether to chase T2T, or diagnosing switch errors invisible to N50/BUSCO/QV.

日本語の概要は準備中です。原文の説明を表示しています。

Identifies differential m6A methylation between conditions from MeRIP-seq paired IP/input data using exomePeak2 with `bam_ip` + `bam_input` (control arm) and `bam_treated_ip` + `bam_treated_input` (treatment arm) for integrated GC-bias-aware differential calling (Liu 2022 *NAR Genom Bioinform* 4:lqac046), QNB beta-binomial test (Liu 2017 *BMC Bioinformatics* 18:387), MeTDiff HMM-based differential bundled with MeTPeak, RADAR (Zhang 2019 *Genome Biol* 20:294) with its `filterBins -> diffIP -> reportResult` workflow, and the defensible paired-symmetric case of edgeR / DESeq2 on featureCounts-on-peaks matrices when batch / lot covariates need explicit fixed-effect handling (exomePeak2's top-level API does NOT accept arbitrary covariates). Covers paired vs unpaired vs interaction designs, batch confounding (antibody lot, RNA prep, sequencing run) and the per-lot meta-analysis strategy when exomePeak2 is the primary caller, the stoichiometry-vs-expression-vs-IP-efficiency confound that all MeRIP differential methods inherit, normalisation choice (size factor on IP, on input, on per-sample IP/input ratio), the McIntyre 2020 reproducibility caveat, effect-size filtering as a guardrail against under-powered N=2 designs, and orthogonal-validation routes for absolute stoichiometry (GLORI / SAC-seq / m6Anet `mod_ratio`). Use when comparing m6A levels across two or more conditions, choosing between exomePeak2 / QNB / RADAR / MeTDiff for a given design, handling batch confounding when exomePeak2's API is too rigid, normalising against input properly, distinguishing real hyper- / hypo-methylation from expression-level shifts, applying effect-size thresholds, interpreting volcano plots of differential peaks, or planning a follow-up orthogonal stoichiometry validation.

日本語の概要は準備中です。原文の説明を表示しています。

Designs and analyzes pooled prime-editor (PE) screens for installing precise genetic variants without bystander confounding. Covers pegRNA design with PRIDICT and PRIDICT2 (Mathis 2023/2024) for predicting per-pegRNA editing efficiency, pegRNA architecture (spacer + scaffold + PBS + RTT), PE2 / PE3 / PE3b / PEmax / PEAR variants, MOSAIC in situ saturation mutagenesis (Hsu JY et al 2024 bioRxiv), the PRIME pooled-screen methodology (Erwood/Doman 2023 Nat Biotechnol 41:885; ~3,699 ClinVar variant screens), chromatin context as a primary determinant of PE efficiency, scaffold-incorporation and indel byproduct quantification with CRISPResso2, and the cross-modal validation strategy of PE + base-editor screens for variant function. Use when designing a pegRNA library for variant installation, choosing between BE and PE for a specific edit, predicting pegRNA efficiency before library synthesis, analyzing PE screen output, distinguishing intended-edit from scaffold-incorporation, or scaling PE screens to thousands of variants.

日本語の概要は準備中です。原文の説明を表示しています。

Implements missing-data sensitivity analyses for confirmatory clinical trials including MMRM under MAR (with Kenward-Roger correction), reference-based multiple imputation (J2R, CR, CIR, LMCF per Carpenter-Roger 2013), Permutt delta-adjustment / tipping-point analysis, pattern-mixture identifying restrictions (CCMV, NCMV, ACMV), and the Cro vs Bartlett variance debate. Use when handling missing primary or secondary endpoint data in regulatory submissions following NRC 2010 and ICH E9(R1).

日本語の概要は準備中です。原文の説明を表示しています。

Assesses RNA-seq data quality specifically for alternative splicing analysis. QC layers include experimental design audit (library prep, read length, depth, replicates), STAR 2-pass cohort-style alignment, junction saturation curves and discovery plateau detection, novel-vs-known junction ratio diagnostics, junction-overhang distribution, splice-site strength scoring (MaxEntScan intrinsic + SpliceAI context-aware), strandedness verification, GENCODE basic vs comprehensive choice, and rRNA contamination screening. Splicing analysis is more demanding than DGE on read length, depth, library prep, alignment strategy, and annotation choice — failures silently bias PSI estimates and inflate novel-junction false positives. Use when evaluating data suitability for splicing analysis, troubleshooting low event detection, or designing sequencing experiments where AS is a primary endpoint.

日本語の概要は準備中です。原文の説明を表示しています。

Create, iterate, and scale paid ad creative for Google Ads, Meta, LinkedIn, TikTok, and similar platforms. Use when generating headlines, descriptions, primary text, or large sets of ad variations for testing and performance optimization.

日本語の概要は準備中です。原文の説明を表示しています。

Extract typical annual GPP, annual evapotranspiration, mid-season LAI, mid-season root biomass, mid-season shoot biomass, median canopy height, maximum primary-root depth, Vcmax at 25oC, and Jmax at 25oC from EcoSIM h0 NetCDF output files. Use when asked to derive these EcoSIM output targets from a selected .ecosim.h0.*.nc file for model-output processing, trait checks, or benchmark summaries.

日本語の概要は準備中です。原文の説明を表示しています。

Download NASA GES DISC NLDAS_FORA0125_H version 2.0 primary hourly forcing data for a point location. Use when Codex needs to retrieve NLDAS File A meteorological forcing from the GES DISC API or HTTPS archive for a longitude/latitude pair, including Earthdata username/password authentication, hourly URL generation, nearest-grid-point extraction, CSV output, or EcoSIM climate-forcing preprocessing.

日本語の概要は準備中です。原文の説明を表示しています。

Material-3-derived dark festival system: deep charcoal surfaces, golden-yellow primary, cyan and lavender accents. Expressive, event-led, full tonal token set.

日本語の概要は準備中です。原文の説明を表示しています。